Specify a stock or a cryptocurrency in the search bar to get a summary
Abcam PLC
ABCMAbcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. Address: Discovery Drive, Cambridge, United Kingdom, CB2 0AX
Analytics
WallStreet Target Price
24.01 USDP/E ratio
2397Dividend Yield
0.75 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ABCM
Dividend Analytics ABCM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ABCM
Stock Valuation ABCM
Financials ABCM
Results | 2019 | Dynamics |